Skip to main content

Table 5 Univariable analysis of in-hospital survival in admitted COVID-19 Asian/Indian patients (n = 61)

From: Racial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia

Variable/category Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
MP dose   0.0246   0.0237
 LD MP vs NMP 0.16 (0.04,0.62) 0.0080 0.13 (0.03,0.61) 0.0101
 HD MP vs NMP 0.24 (0.06,0.92) 0.0371 0.15 (0.04,0.64) 0.0106
 HD MP vs LD MP 1.52 (0.45,5.12) 0.5005 1.21 (0.42,3.49) 0.7287
Diabetes 1.38 (0.54,3.54) 0.5023   
Hypertension 2.40 (0.83,6.91) 0.1047   
Chronic kidney disease 4.77 (1.96,11.62) 0.0006 6.36 (1.87,21.67) 0.0031
Male vs female 0.58 (0.23,1.45) 0.2421   
Respiratory rate > 22 bpm 1.24 (0.50,3.08) 0.6489   
Older age ≥ 60 years 9.45 (1.22,72.98) 0.0313   
Obesity status BMI ≥ 30 kg/m2 1.61 (0.66,3.92) 0.2922   
Cancer 1.19 (0.24,5.80) 0.8297   
CRP > 20 mg/L 4.46 (1.64,12.10) 0.0033 5.02 (1.72,14.66) 0.0032
Ferritin ≥ 1400 μg/L 0.35 (0.12,1.03) 0.0577   
Supplemental oxygen   0.5732   
 NMV vs none 1.96 (0.56,6.87) 0.2914   
 MV vs none 1.66 (0.38,7.26) 0.5015   
qSOFA   0.5020   
 qSOFA 1 vs 0 0.90 (0.37,2.22) 0.8251   
 qSOFA 2 vs 0 2.43 (0.45,13.04) 0.2987   
Creatinine ≥ 1.5 mg/dL 2.26 (0.85,6.03) 0.1031   
  1. Risk of in-hospital mortality by Cox regression model. Any P < 0.05 was statistically significant
  2. MV mechanical ventilation; NMV non-mechanical ventilation; HR hazard ratio; CI confidence interval